BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE:VEEV) today announced the availability of Veeva Vault EDC to help clinical data management teams better run clinical trials. Veeva Vault EDC ...
PLEASANTON, Calif., Oct. 13, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced two new Veeva Link applications to help clinical teams improve site selection and optimize trial design.
Veeva Systems (VEEV) delivered strong third-quarter results, beating revenue and earnings estimates while sharing an upbeat outlook for the rest of the fiscal year. The company is highlighting ...
Despite a reduction in guidance for FY 2023, Veeva Systems still has strong growth prospects in the healthcare sector. The potential for the Fed to stop raising interest rates could provide more ...
I rate Veeva Systems Inc. as a buy due to the recent 0.5% interest rate cut from the FED, boosting demand from recovering SMB biotech firms. Veeva's Q2 FY2025 results exceeded expectations, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback